| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10610523 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(3 years from now) | |
| US8835460 | BTCP PHARMA | Sublingual fentanyl spray and methods of treating pain |
Jan, 2027
(3 years from now) | |
| US9642797 | BTCP PHARMA | Sublingual fentanyl spray and methods of use to treat pain |
Jan, 2027
(3 years from now) | |
| US9289387 | BTCP PHARMA | Method of treating pain by administering sublingual fentanyl spray |
Jan, 2027
(3 years from now) | |
| US9642844 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(3 years from now) | |
| US8835459 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(3 years from now) | |
| US10016403 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(3 years from now) | |
| US9241935 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(3 years from now) | |
| US8486973 | BTCP PHARMA | Sublingual fentanyl spray |
Apr, 2030
(6 years from now) | |
| US8486972 | BTCP PHARMA | Sublingual fentanyl spray |
Apr, 2030
(6 years from now) | |
Subsys is owned by Btcp Pharma.
Subsys contains Fentanyl.
Subsys has a total of 10 drug patents out of which 0 drug patents have expired.
Subsys was authorised for market use on 04 January, 2012.
Subsys is available in spray;sublingual dosage forms.
Subsys can be used as treatment of pain.
The generics of Subsys are possible to be released after 27 April, 2030.
Drugs and Companies using FENTANYL ingredient
Market Authorisation Date: 04 January, 2012
Treatment: Treatment of pain
Dosage: SPRAY;SUBLINGUAL
SUBSYS family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic